Topical agents, alternative medicine, and disease severity assessment are the subjects of the latest updated set of guidelines for the management and treatment of psoriasis issued jointly by the ...

Please provide your email address to receive an email when new articles are posted on . Topical medications are widely preferred by physicians and patients to treat psoriasis. Steroidal agents should ...

For people with moderate to severe psoriasis, highly targeted antibody-based treatments introduced in the past 10–15 years have been life changing. Inflamed skin covering swathes of the body often ...

Patients with moderate psoriasis, defined by 3%-10% BSA, are now eligible for systemic therapy under updated IPC guidelines. Risankizumab treatment for 12 months resulted in significant PASI score ...

For many people living with psoriasis, finding a treatment that truly works can feel life-changing — clearer skin, fewer flares, and a sense of control. But before some people can access the most ...

Psoriasis, a chronic autoimmune condition, causes inflammation in the skin, most often leading to thick, scaly areas called plaques. An overactive immune system speeds up skin cell development, ...